Table 1.
AD demography and patient characteristics
| Reference | Type of Study | Study Period | Patient Population | Definition/Identification criteria | No. of cases | N | F: M (% males) | Disease severity assessment criteria | Age range | Age at onset | Severity | Prevalence | Incidence | Co- morbidities |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Narayan 2019[26] | Hospital- based cross- sectional study | ~ | AD patients | Hanifin and Rajka’s criteria | 55 | 55 | 26/29 (52.7%) | SCORAD | ~ | 2.13±2.10 | Mild - 32.7% Moderate-to -severe - 56.4% Severe 10.9% Mean SCORAD score - 32.02±12.16 | ~ | ~ | ~ |
| Kumar 2014[27] | Hospital- based , point- prevalence, cross-sectional study | 20-Nov-12 (single day) | Psoriasis, vitiligo, and AD patients | Hanifin and Rajka’s criteria | ~ | 4785 | 1.25:1 | ~ | ~ | ~ | ~ | Point prevalence: 6.75% | ~ | ~ |
| Kumar 2014[23] | Prospective hospital-based study | January 2010 to December 2011 | ~ | 132 | 1829 | 75/57 (43.2%) | SCORAD | 0 months to 15 years | Infantile (<1 years) - 5.2 (± 3.01) months Childhood (1 to 15) – 3.47 (± 3.02) years | SCORAD Infantile Mild - 17.8±4.29 Moderate - 38.35±8.28 Severe - 88.42±14.24 SCORAD Childhood Mild - 12.3±5.1 Moderate - 33.3±7.5 Severe - 64.9±11.89 | 7.21% of all pediatric dermatoses | ~ | ~ | |
| Agarwal 2014[25] | Not mentioned | 5 years | Vitiligo patients | ~ | 25 | 268 | ~ | ~ | 1 month to 72 years | ~ | ~ | 4.9% | ~ | Vitiligo |
| Sehgal 2015[28] | Cross- sectional descriptive study | May 2010 - December 2011 | AD patients | Hanifin and Rajka’s criteria | 100 | 100 | 35/65 (65%) | SASSAD | <2 years to >18 years | 3.63±1.42 | Mean SASSAD - 38.46±12.69 | Overall: 0.98% (new plus old cases) 0.24% (newly diagnosed cases) | ~ | ~ |
| Kumar 2019[29] | Cross-sectional study | June 2017 to August 2017 | Asthma patients | ~ | 26 | 95 | 6/20 (76.9%) | ~ | 5-15 years | ~ | ~ | 27.4% | ~ | Asthma |
| Qureshi 2016[24] | Community- based cross-sectional study | 15 March 2012 to 15 May 2013 | School children (epidemiology study for bronchial asthma) | ~ | 25 | 806 | ~ | ~ | 10 to 16 years | ~ | ~ | 3.1% | ~ | Bronchial asthma |
| Grills 2012[30] | Cross-sectional cluster | March 2010 | General population (prevalence survey for dermatological conditions) | ~ | 111 | 1250 | ~ | ~ | <5 years to>65 years | ~ | ~ | 9.2% | ~ | ~ |
| Upendra 2017[22] | Cross-sectional study | ~ | AD patients | Hanifin and Rajka’s criteria | 90 | 1943 | 52/38 (42.2%) | SCORAD | 6-16 years | 2.14±0.5 | Mild - 84.4% Moderate - 13.3% Severe - 2.2% | 4.60% | ~ | Allergic rhinitis - 27.8% Bronchial asthma - 13.3% |
F: M, female: male; N, number; SASSAD, Six Area Six Sign Atopic Dermatitis; SCORAD, SCORing Atopic Dermatitis